Literature DB >> 17654194

What should be the maximum FSH dose in IVF/ICSI in poor responders?

C S Siristatidis1, M P Hamilton.   

Abstract

Various protocols of ovarian stimulation have been proposed for optimising IVF/ICSI results in women presenting with a poor response to controlled ovarian stimulation; however, achieving a good response to stimulation for this category of patients still remains a challenge. The most extensively employed strategy to improve follicular response in these so-called 'poor responders' involves the use of high doses of gonadotrophins. A small number of randomised controlled trials and retrospective studies have evaluated the effectiveness of the high-dose FSH regimes over a 300 IU threshold. The results of these studies have shown these approaches to be of little or no clinical benefit, although both the costs of treatment and side-effects were higher. There are other studies that have examined 450 IU FSH regimens or even more. This paper presents an overview in all these clinical trials, trying to evaluate the safest and most effective upper limit of FSH that may be used for controlled ovarian hyperstimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654194     DOI: 10.1080/01443610701327420

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  6 in total

1.  Does the addition of clomiphene citrate or letrazole to gonadotropin treatment enhance the oocyte yield in poor responders undergoing IVF?

Authors:  Vuk P Jovanovic; Daniel H Kort; Michael M Guarnaccia; Mark V Sauer; Rogerio A Lobo
Journal:  J Assist Reprod Genet       Date:  2011-10-12       Impact factor: 3.412

2.  Enough is enough! Patients who do not conceive on 600 IU/d of gonadotropins show no improvement from an additional 150 IU of LH activity.

Authors:  Marcy Maguire; John Csokmay; James Segars; Mark Payson; Alicia Armstrong
Journal:  Fertil Steril       Date:  2010-09-17       Impact factor: 7.329

Review 3.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

4.  Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women.

Authors:  Norbert Gleicher; Ann Kim; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2012-06-20       Impact factor: 5.211

5.  Effect of Antagonist Start Day on Cycle Outcomes in Poor Responders.

Authors:  Inci Kahyaoglu; Hatice Y Dogru; Iskender Kaplanoglu; Ayse Seval Ozgu-Erdinc; Serdar Dilbaz; Leyla Mollamahmutoglu
Journal:  J Hum Reprod Sci       Date:  2021-12-31

6.  Comparison of The Effectiveness of Clomiphene Citrate versus Letrozole in Mild IVF in Poor Prognosis Subfertile Women with Failed IVF Cycles.

Authors:  Mesut Oktem; Ismail Guler; Mehmet Erdem; Ahmet Erdem; Nuray Bozkurt; Onur Karabacak
Journal:  Int J Fertil Steril       Date:  2015-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.